• OPEN AN ACCOUNT
A+| A| A-|
Indian Indices
Sensex
74,243.34 -116.67
( -0.16%)
Global Indices
Nasdaq
51,596.42 888.35
(1.75%)
Dow Jones
7,607.58 32.90
(0.43%)
Hang Seng
66,711.59 -759.10
(-1.13%)
Nikkei 225
10,347.89 15.59
(0.15%)
Forex
USD-INR
95.72 0.48
(0.51%)
EUR-INR
111.14 0.31
(0.28%)
GBP-INR
128.64 0.40
(0.31%)
JPY-INR
0.60 0.00
(0.43%)

EQUITY - MARKET SCREENER

Dipna Pharmachem Ltd
Industry :  Pharmaceuticals - Indian - Bulk Drugs & Formln
BSE Code
ISIN Demat
Book Value()
543594
INE0MC401013
15.7559345
NSE Symbol
P/E(TTM)
Mar.Cap( Cr.)
N.A
19.41
18.88
EPS(TTM)
Face Value()
Div & Yield %
0.37
10
0
 

Vedanta consolidated net profit rises 92.31% in the March 2026 quarter
May 04,2026
Net profit of Vedanta rose 92.31% to Rs 6698.00 crore in the quarter ended March 2026 as against Rs 3483.00 crore during the previous quarter ended March 2025. Sales rose 44.59% to Rs 23731.00 crore in the quarter ended March 2026 as against Rs 16413.00 crore during the previous quarter ended March 2025.

For the full year,net profit rose 16.03% to Rs 17391.00 crore in the year ended March 2026 as against Rs 14988.00 crore during the previous year ended March 2025. Sales rose 24.46% to Rs 76672.00 crore in the year ended March 2026 as against Rs 61605.00 crore during the previous year ended March 2025.

ParticularsQuarter EndedYear Ended
Mar. 2026Mar. 2025% Var.Mar. 2026Mar. 2025% Var.
Sales23731.0016413.00 45 76672.0061605.00 24
OPM %31.8531.96 -30.2430.16 -
PBDT7240.004522.00 60 21916.0016212.00 35
PBT5908.003331.00 77 17106.0011979.00 43
NP6698.003483.00 92 17391.0014988.00 16